Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Eleni Gavriilaki(Aristotle University of Thessaloniki), Ioanna Sakellari(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital), Georgia Gkioula(Aristotle University of Thessaloniki), Christos Demosthenous(G. Papanikolaou General Hospital), Anna Papakonstantinou(Aristotle University of Thessaloniki), E. Laspa(University Hospital of Geneva), Eirini Baldoumi(American Institute of Biological Sciences), Ioannis Batsis(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Anna Vardi(G. Papanikolaou General Hospital), Christos Varelas(G. Papanikolaou General Hospital), Andriana Lazaridou(G. Papanikolaou General Hospital), Despina Mallouri(G. Papanikolaou General Hospital), Aggeliki Giannakopoulou(G. Papanikolaou General Hospital)
Cited by 7
Related Papers
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
|Blood|2013|93
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63